Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)
HKD 0.28
(0.0%)
HKD 0.28
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.79 Million CNY | 132.0% |
| 2022 | -2.26 Million CNY | -206.84% |
| 2021 | -29.85 Million CNY | 134.61% |
| 2020 | -14.64 Million CNY | -9.91% |
| 2019 | -13.32 Million CNY | 62.46% |
| 2018 | -35.48 Million CNY | -439.26% |
| 2017 | 3.81 Million CNY | -51.79% |
| 2016 | 21.69 Million CNY | -53.29% |
| 2015 | 46.45 Million CNY | 4.16% |
| 2014 | 44.6 Million CNY | 7.19% |
| 2013 | 41.6 Million CNY | -12.76% |
| 2012 | 47.69 Million CNY | 33.68% |
| 2011 | 35.67 Million CNY | 66.96% |
| 2010 | 21.36 Million CNY | 1.03% |
| 2009 | 21.15 Million CNY | 52.9% |
| 2008 | 13.83 Million CNY | 122.48% |
| 2007 | 6.51 Million CNY | -28.67% |
| 2006 | 15.58 Million CNY | 39.33% |
| 2005 | 6.91 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 300.66 Thousand CNY | 0.0% |
| 2024 Q1 | 300.66 Thousand CNY | -96.03% |
| 2023 FY | - CNY | 132.0% |
| 2023 Q3 | -4.84 Million CNY | 14.84% |
| 2023 Q4 | 7.56 Million CNY | 256.04% |
| 2023 Q1 | -6.92 Million CNY | -126.85% |
| 2023 Q2 | -5.69 Million CNY | 17.79% |
| 2022 Q3 | -8.02 Million CNY | -83.82% |
| 2022 Q4 | -3.05 Million CNY | 61.94% |
| 2022 Q1 | -5.36 Million CNY | 31.66% |
| 2022 FY | - CNY | -206.84% |
| 2022 Q2 | -4.36 Million CNY | 18.73% |
| 2021 Q3 | 2.34 Million CNY | -5.72% |
| 2021 Q4 | -7.85 Million CNY | -435.09% |
| 2021 FY | - CNY | 134.61% |
| 2021 Q1 | -1.42 Million CNY | 77.93% |
| 2021 Q2 | 2.48 Million CNY | 275.11% |
| 2020 Q2 | 2.06 Million CNY | 137.37% |
| 2020 Q4 | -6.43 Million CNY | 45.61% |
| 2020 FY | - CNY | -9.91% |
| 2020 Q1 | -5.52 Million CNY | 67.18% |
| 2020 Q3 | -11.82 Million CNY | -672.63% |
| 2019 Q4 | -16.84 Million CNY | -150.29% |
| 2019 Q1 | -2.19 Million CNY | 93.39% |
| 2019 Q3 | -6.72 Million CNY | -206.57% |
| 2019 FY | - CNY | 62.46% |
| 2019 Q2 | -2.19 Million CNY | -0.0% |
| 2018 Q2 | 3 Million CNY | 146.22% |
| 2018 FY | - CNY | -439.26% |
| 2018 Q4 | -33.19 Million CNY | -45.8% |
| 2018 Q3 | -22.76 Million CNY | -857.87% |
| 2018 Q1 | -6.49 Million CNY | -105.93% |
| 2017 Q4 | -3.15 Million CNY | 15.41% |
| 2017 Q3 | -3.73 Million CNY | -294.38% |
| 2017 Q1 | -1.87 Million CNY | 79.09% |
| 2017 FY | - CNY | -51.79% |
| 2017 Q2 | -945.98 Thousand CNY | 49.44% |
| 2016 Q4 | -8.94 Million CNY | -231.09% |
| 2016 Q2 | 9.2 Million CNY | 230.89% |
| 2016 Q1 | 2.78 Million CNY | -77.01% |
| 2016 FY | - CNY | -53.29% |
| 2016 Q3 | 6.82 Million CNY | -25.85% |
| 2015 Q4 | 12.09 Million CNY | -32.75% |
| 2015 FY | - CNY | 4.16% |
| 2015 Q3 | 17.98 Million CNY | 261.37% |
| 2015 Q2 | 4.97 Million CNY | 217.44% |
| 2015 Q1 | 1.56 Million CNY | -89.43% |
| 2014 Q3 | 6.21 Million CNY | -24.02% |
| 2014 Q2 | 8.18 Million CNY | 44.26% |
| 2014 Q4 | 14.84 Million CNY | 138.62% |
| 2014 Q1 | 5.67 Million CNY | -46.09% |
| 2014 FY | - CNY | 7.19% |
| 2013 Q1 | 12.37 Million CNY | -53.19% |
| 2013 FY | - CNY | -12.76% |
| 2013 Q3 | 5.91 Million CNY | 67.02% |
| 2013 Q2 | 3.54 Million CNY | -71.38% |
| 2013 Q4 | 10.52 Million CNY | 77.93% |
| 2012 Q1 | 3.04 Million CNY | -61.89% |
| 2012 Q2 | 3.18 Million CNY | 4.74% |
| 2012 FY | - CNY | 33.68% |
| 2012 Q3 | 5.41 Million CNY | 70.07% |
| 2012 Q4 | 26.43 Million CNY | 388.03% |
| 2011 Q3 | 8.18 Million CNY | 44.45% |
| 2011 Q1 | 3.58 Million CNY | 17.77% |
| 2011 Q2 | 5.66 Million CNY | 58.29% |
| 2011 Q4 | 7.97 Million CNY | -2.55% |
| 2011 FY | - CNY | 66.96% |
| 2010 Q3 | 4.53 Million CNY | 33.74% |
| 2010 Q2 | 3.38 Million CNY | 0.0% |
| 2010 Q4 | 3.04 Million CNY | -32.88% |
| 2010 FY | - CNY | 1.03% |
| 2009 FY | - CNY | 52.9% |
| 2009 Q2 | 187.37 Thousand CNY | 0.0% |
| 2008 FY | - CNY | 122.48% |
| 2007 FY | - CNY | -28.67% |
| 2006 FY | - CNY | 39.33% |
| 2005 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|